my 2 cents:

1) phase 2 covid-19 trial: 1 month to run and 1 month to analyze data and make annoucement

-> w/ positive results, small upward mvmt in share price

2) phase 3 covid-19 trial: 3 months to run and 1 month to analyze data and annouce results

-> w/ positive results, exponential growth of share price

give additional ~1-2 months to each P2 and P3 trials just to make sure everything is checked.

by the end of this year (2021), investors will be "prosperous"....